Hammadul Hoque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hammadul Hoque has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
G. M. Nurnabi Azad Jewel
Department of Genetic Engineering and Biotechnology, Shahjalal University of Science and Technology, Sylhet, Bangladesh
3 shared publicationsMahmudul Hasan
Department of Genetic Engineering and Biotechnology, Shahjalal University of Science and Technology, Sylhet, Bangladesh
2 shared publicationsMashiur Rahaman
Department of Genetic Engineering and Biotechnology, School of Life Sciences, Shahjalal University of Science and Technology, Sylhet, Bangladesh
2 shared publications- Nurnabi Azad Jewel
Shahjalal University of Science and Technology
2 shared publications Rahatul Islam
Department of Genetic Engineering and Biotechnology, School of Life Sciences, Shahjalal University of Science and Technology, Sylhet, Bangladesh
2 shared publicationsAbunasar Miah
Department of Biotechnology and Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh
1 shared publication
Latest Publications
- 7 July 2025
- Published by Springer Nature in In Silico Pharmacology
- Vol. 13 (2) , 98
Comprehensive immunoinformatics guided design and in silico assessment of a multi-epitope vaccine to elicit immunity against Mayaro virus
The Mayaro virus (MAYV), an emerging arbovirus of the Alphavirus genus (family Togaviridae), shares clinical and epidemiological features with other arboviruses such as Chikungunya, Dengue, and Zika. It causes Mayaro fever in humans, characterized by febrile illness and prolonged arthralgia, often leading to misdiagnosis. Given the absence of licensed vaccines or antiviral therapies and the presence of competent vectors in endemic regions, MAYV poses a significant threat of epidemic, particularly in rural South America. In this research, computational immunological methods were employed to construct a polypeptide vaccine, with a focus on the structural polyprotein of the Mayaro virus. A series of rigorous computational assessments were used to predict the most potent T and B lymphocyte epitopes for the vaccine candidate. The vaccine exhibited favorable physicochemical properties, stable secondary and tertiary structures, and high solubility. Molecular dynamics simulations demonstrated its structural stability, while docking studies indicated robust interactions with TLR2 and TLR4 receptors, essential for initiating immune responses. Codon optimization, along with in silico cloning, demonstrated efficient expression of the vaccine candidate in an E. coli system. Finally, an immune simulation indicated that the vaccine candidate could induce a robust and long-lasting immune response.
- 7 July 2025
- Published by Springer Nature in In Silico Pharmacology
- Vol. 13 (2) , 98
Comprehensive immunoinformatics guided design and in silico assessment of a multi-epitope vaccine to elicit immunity against Mayaro virus
The Mayaro virus (MAYV), an emerging arbovirus of the Alphavirus genus (family Togaviridae), shares clinical and epidemiological features with other arboviruses such as Chikungunya, Dengue, and Zika. It causes Mayaro fever in humans, characterized by febrile illness and prolonged arthralgia, often leading to misdiagnosis. Given the absence of licensed vaccines or antiviral therapies and the presence of competent vectors in endemic regions, MAYV poses a significant threat of epidemic, particularly in rural South America. In this research, computational immunological methods were employed to construct a polypeptide vaccine, with a focus on the structural polyprotein of the Mayaro virus. A series of rigorous computational assessments were used to predict the most potent T and B lymphocyte epitopes for the vaccine candidate. The vaccine exhibited favorable physicochemical properties, stable secondary and tertiary structures, and high solubility. Molecular dynamics simulations demonstrated its structural stability, while docking studies indicated robust interactions with TLR2 and TLR4 receptors, essential for initiating immune responses. Codon optimization, along with in silico cloning, demonstrated efficient expression of the vaccine candidate in an E. coli system. Finally, an immune simulation indicated that the vaccine candidate could induce a robust and long-lasting immune response.
- Open Access
- 28 January 2022
- Published by Springer Nature in Research Square
Immunoinformatics guided design of a universal epitope-based vaccine against Kaposi Sarcoma
The Kaposi sarcoma-associated herpesvirus (KSHV) is a virus that is identified as a direct carcinogen, causes Kaposi sarcoma, primary effusion lymphoma and multicentric Castleman disease. Despite this, there is no permanent treatment. This work intended to develop a multi-epitope vaccine aiming KSHV's key glycoproteins involved in viral entry. After applying rigorous immunoinformatics study and numerous immunological filters, the multi epitope vaccine was created, comprising of potent CTL, HTL and BCL epitope. A series of computational evaluations established the general dependability of the putative vaccine, and a molecular dynamics simulation established the vaccine's overall stability. Docking experiments revealed that the vaccination can make stable interactions with Toll-Like Receptors. Codon optimization and insertion into the cloning vector revealed that the vaccine could be expressed proficiently in the E. coli expression system. Finally, an immune simulation was done to assess the vaccine's potency to trigger an immune response.
- 28 January 2022
- Published by Springer Nature in Research Square
Open AccessImmunoinformatics guided design of a universal epitope-based vaccine against Kaposi Sarcoma
The Kaposi sarcoma-associated herpesvirus (KSHV) is a virus that is identified as a direct carcinogen, causes Kaposi sarcoma, primary effusion lymphoma and multicentric Castleman disease. Despite this, there is no permanent treatment. This work intended to develop a multi-epitope vaccine aiming KSHV's key glycoproteins involved in viral entry. After applying rigorous immunoinformatics study and numerous immunological filters, the multi epitope vaccine was created, comprising of potent CTL, HTL and BCL epitope. A series of computational evaluations established the general dependability of the putative vaccine, and a molecular dynamics simulation established the vaccine's overall stability. Docking experiments revealed that the vaccination can make stable interactions with Toll-Like Receptors. Codon optimization and insertion into the cloning vector revealed that the vaccine could be expressed proficiently in the E. coli expression system. Finally, an immune simulation was done to assess the vaccine's potency to trigger an immune response.
- Open Access
- 26 October 2021
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 19 (1) , 167-14
Characterization of transcription factor MYB59 and expression profiling in response to low K+ and NO3− in indica rice (Oryza sativa L.)
- 26 October 2021
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 19 (1) , 167-14
Open AccessCharacterization of transcription factor MYB59 and expression profiling in response to low K+ and NO3− in indica rice (Oryza sativa L.)
- 8 March 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (16) , 7256-7273
Implementation of computational approaches to explore the deleterious effects of non-synonymous SNPs on pRB protein
Retinoblastoma 1 (RB1) is the first discovered tumor suppressor gene and recognized as the simple model system whose encoded defective protein can cause a pediatric cancer retinoblastoma. It functions as a negative regulator of the cell cycle through the interactions with members of the E2F transcription factors family. The protein of the RB1 gene (pRB) is engaged in various cell cycle processes including apoptosis, cell cycle arrest and chromatin remodeling. Recent studies on Retinoblastoma also exhibited multiple sets of point mutation in the associated protein due to its large polymorphic information in the local database. In this study, we identified the list of disease associated non-synonymous single nucleotide polymorphisms (nsSNPs) in RB1 by incorporating different computational algorithms, web servers, modeling of the mutants and finally superimposing it. Out of 826 nsSNPs, W516G and W563G were predicted to be highly deleterious variants in the conserved regions and found to have an impact on protein structure and protein-protein interaction. Moreover, our study concludes the effect of W516G variant was more detrimental in destabilizing protein’s nature as compared to W563G variant. We also found defective binding of pRB having W516G mutation with E2F2 protein. Findings of this study will aid in shortening of the expensive experimental cost of identifying disease associated SNPs in retinoblastoma for which specialized personalized treatment or therapy can be formulated. Communicated by Ramaswamy H. Sarma
- 8 March 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (16) , 7256-7273
Implementation of computational approaches to explore the deleterious effects of non-synonymous SNPs on pRB protein
Retinoblastoma 1 (RB1) is the first discovered tumor suppressor gene and recognized as the simple model system whose encoded defective protein can cause a pediatric cancer retinoblastoma. It functions as a negative regulator of the cell cycle through the interactions with members of the E2F transcription factors family. The protein of the RB1 gene (pRB) is engaged in various cell cycle processes including apoptosis, cell cycle arrest and chromatin remodeling. Recent studies on Retinoblastoma also exhibited multiple sets of point mutation in the associated protein due to its large polymorphic information in the local database. In this study, we identified the list of disease associated non-synonymous single nucleotide polymorphisms (nsSNPs) in RB1 by incorporating different computational algorithms, web servers, modeling of the mutants and finally superimposing it. Out of 826 nsSNPs, W516G and W563G were predicted to be highly deleterious variants in the conserved regions and found to have an impact on protein structure and protein-protein interaction. Moreover, our study concludes the effect of W516G variant was more detrimental in destabilizing protein’s nature as compared to W563G variant. We also found defective binding of pRB having W516G mutation with E2F2 protein. Findings of this study will aid in shortening of the expensive experimental cost of identifying disease associated SNPs in retinoblastoma for which specialized personalized treatment or therapy can be formulated. Communicated by Ramaswamy H. Sarma